Could a transplant shield a child’s brain from silent damage compared to standard care? A 10-year study has some answers.

Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive blood cancer. From chemo to engineered immune cells, here is what patients need to know in 2026.

A major review in Leukemia argues the evidence now supports using interferon-alpha as first-line therapy for nearly all PV patients — from diagnosis, not as a last resort.